Document is current
Any future updates will be listed below
-
Authors
Cortesi, Paolo Angelo
Antonazzo, Ippazio Cosimo https://orcid.org/0000-0001-8046-4574
Palladino, Pasquale
Gnesi, Marco
Mele, Silvia
D’Amelio, Marco
Zanzottera Ferrari, Elena
Mazzaglia, Giampiero
Mantovani, Lorenzo Giovanni
-
Funding
Funding for this research was provided by:
AstraZeneca (No number)
Università degli Studi di Milano - Bicocca
- License Information
-
More Information
Article History
Received: 28 December 2023
Accepted: 19 March 2024
First Online: 18 April 2024
Declarations
:
: I.C.A. declares no conflicts of interest. P. A. C. has received a research grant from Baxalta, now part of Shire, and speaking honoraria from Pfizer and Roche. E.Z and P.P are employees of Cegedim Srl, which is a private company that performs financially supported studies for several pharmaceutical companies. M.G., S.M., M.D.A., are employees of AstraZeneca. G.M reports received grants from CLS Behring for consultancy outside this work. L. G. M. has received grants and personal fees from Bayer AG, Boehringer Ingelheim, Pfizer and Daiichi-Sankyo.
: Ethical approval is not required for simulation-based studies in the present study’s jurisdiction.
: Not applicable.
